Premier Research Institute Launches India's First Ayurvedic Anti-Diabetic Drug in kerala

Feb 24 , 2016


Aimil Healthcare

Premier Research Institute Launches India's First Ayurvedic Anti-Diabetic Drug in kerala


Kozhikode:  The Council for Scientific and Industrial Research (CSIR) today launched the country's first anti-diabetic ayurvedic drug for type two Diabetes mellitus.

The drug BGR-34 is developed jointly by National Botanical Research Institute (NBRI) and Central Institute for Medicinal and Aromatic Plants (CIMAP), the Lucknow-based research units of CSIR.

Launching the drug at a function in Kozhikode, Senior Principal Scientist, CSIR-NBRI, Dr A K S Rawat said, "Six crore adult Indian population has been found to be diabetic and there is no effective solution for diabetes as yet. We are sure that eminent medical professionals will recommend it to their patients suffering from type two Diabetes mellitus for quicker and consistent response."

"The scientists of NBRI and CIMAP joined hands to develop an effective, safe, patient-friendly solution towards management of type two Diabetes. While the modern diabetes drugs are known for side-effects and toxicity, BGR-34 works by controlling blood sugar and limiting the harmful effects of other drugs," he said.

Dr Ch V Rao, Principal Scientist CSIR-NBRI said, "BGR-34 is a unique product that manages the lives of people suffering from diabetes. One of the critical ingredients is that it inhibits DPP-4 and enhances insulin secretion. The product has passed several battery of tests and showed hypoglycemic activity in experimental subjects."

For the purpose of quality commercial production and extended distribution, AIMIL Pharmaceuticals (I) Ltd, known for its innovative Ayurvedic products, has been transferred the rights and technical knowhow to produce and market it for medical use.

K K Sharma, Managing Director of AIMIL pharmaceuticals, said, "We have decided to launch this marvellous anti-diabetic product in the name of BGR-34, which stands for Blood Glucose Regulator, containing 34 identified active phyto-constitutes from herbal resources."

AIMIL pharmaceuticals already had a successful technological collaboration with Defence Research and Development Organisation for effective and safe treatment of leucoderma, still considered a big challenge.

The product for leucoderma was launched in the market in the name of 'Lukoskin', he added.

See below more newspaper coverage:

Ayurveda Medicine

bgr34 diet plan

bgr34 ingredients

bgr34 dosage

Cure Diabetes

diabetes foot

diabetic ingredient

diabetic neuropathy

Diabetic symptoms

prevention of diabetes

recipes of diabetes


  • 24 Feb 2016 jasvindar kaul

    Happy to read this news. Hope all the diabetics like me will be take benefit.

  • 24 Feb 2016 yogi

    If I have some of the risk factors for diabetes, how often should I be tested to find out if I do have it or not?

  • 24 Feb 2016 yogesh

    While being treated for pancreatitis in the ICU for the second time, I was told that my blood sugar was 422 and that I am diabetic. I have not gained any weight, I am on a pretty strict diet and yet my sugar doesn’t run under 200 for more than a day even though I am taking 75 units of Lantus. My doctor has told me to hold off on increasing the units until our next visit. I have not been diagnosed with type 1 or 2! Are there any other tests that could help diagnose the type of diabetes I have?

  • 24 Feb 2016 istkar

    dear yogesh,
    Generally speaking, no, because you are not ingesting toothpaste. However, you do want to pay attention to the ingredients in things like cough syrup and other medicaitons over the counter that may have sugar in them. Many products have sugar free versions. Always ask your pharmacist when you aren’t clear about the best product to buy for diabetes.

  • 24 Feb 2016 yogesh

    Do people with diabetes need to use special toothpaste?

Leave a comment

Please note, comments must be approved before they are published